Source: Annual Congress 2002 - Interstitial lung disease: clinical pathobiology and BAL
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Piesiak, R. Jankowska, W. Szeliga (Wroclaw, Poland). The relationship between the course of sarcoidosis and changes of markers of the disease activity in a bronchoalveolar lavage fluid. Eur Respir J 2002; 20: Suppl. 38, 2960

Member's Comments

No comment yet.

Related content which might interest you: Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis in relation to smoking Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Activation markers of lymphocytes in bronchoalveolar lavage fluid of different sarcoidosis stages Source: Eur Respir J 2003; 22: Suppl. 45, 265s Year: 2003 Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis Source: Eur Respir J 2003; 21: 407-413 Year: 2003 Changes of pneumonia patients bronchoalveolar lavage fluid cellular components Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002 Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters? Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002 Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters? Source: Eur Respir J 2001; 18: Suppl. 33, 507s Year: 2001 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 T-cell cytokine pattern in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 173s Year: 2002 The importance of cytological analysis of bronchoalveolar lavage in tuberculous lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 662s Year: 2007 Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Correlation between imaging fibrosis severity and bronchoalveolar lavage pattern in interstitial lung disease Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases Source: Eur Respir Mon; 2009: 46: 36–46 Year: 2009 Biochemical features of bronchoalveolar lavage cells and fluid in different phases of allergic alveolitis Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001 Influence of smoking on bronchoalveolar lavage cellular pattern in sarcoidosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 The coagulation and antifibrynolitic activities are increased in the bronchoalveolar lavage fluid from patients with progressing idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 575s Year: 2007 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019